CASI Pharmaceuticals (CASI) Stock Trends and Sentiment → Nvidia’s Quiet $1 Trillion Pivot (From Weiss Ratings) (Ad) Free CASI Stock Alerts $3.23 +0.09 (+2.87%) (As of 10:22 AM ET) Add Compare Share Share TrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Media Mentions Over Time1 Last Week 1 Current Week View Trending Media Stocks MarketBeat New Followers Over TimeView Trending Stocks on MarketBeat MarketBeat Searches Over Time1 Last Week 2 Current Week +100.0% Page Views Over Time344 Last Week 609 Current Week +77.0% Recieve CASI Pharmaceuticals News and Ratings via Email Sign-up to receive the latest news and ratings for CASI and its competitors with MarketBeat's FREE daily newsletter. Email Address CASI Social Media Mentions Related Companies and Tools Related Companies: Incannex Healthcare Stock Trends Rezolute Stock Trends Inventiva Stock Trends Capricor Therapeutics Stock Trends Trevi Therapeutics Stock Trends Greenwich LifeSciences Stock Trends Abeona Therapeutics Stock Trends Puma Biotechnology Stock Trends Organigram Stock Trends Rigel Pharmaceuticals Stock Trends Trends Tools: Trending StocksTrending Media MentionsHigh Media Sentiment StocksTrending WallStreetBets StocksLive News Feed This page (NASDAQ:CASI) was last updated on 6/11/2024 by MarketBeat.com Staff From Our Partners[BUY ALERT] Our #1 A.I. Stock for AprilIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Behind the Markets | SponsoredBill Clinton Backing Biden Replacement???According to Louis, it’s a near-certainty that just enough Republicans will abandon Trump to ensure his defeat...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CASI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CASI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
